Kim Caswell

Kim Caswell is a seasoned professional in the clinical research field, currently serving as a Sr. Clinical Scientist at Genmab since November 2021 and as the Owner of Crossroads Medical Research, Inc. Previous experience includes roles at Bristol Myers Squibb/hCelgene as a Clinical Scientific Safety Writer/Manager from February 2015 to October 2021, and as a Global Clinical Submission Specialist at Novartis Consumer Health from September 2013 to January 2015. Kim has also held consulting positions with Lux Biosciences, Celgene, Eisai, and Pfizer, contributing as a Consulting Clinical Study Manager and Sr. Consulting Study Manager. Early career experience includes management roles at Auditrial Clinical Research Consulting and Sandoz/Novartis from 1993 to 1996.